Clinical Trial Update: A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1, open-label, single-arm study assessing the safety and tolerability of 225Ac-TR2205 injection in patients with advanced metastatic triple-negative bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• 225Ac-TR2205

Snippet

Sponsor: Xiaorong Sun | Conditions: Advanced Metastatic Triple-negative Breast Cancer (mTNBC) | EARLY_Phase 1 | Status: RECRUITING